Business Context and Reporting Period
This Form 8-K reports the consummation of the initial public offering (IPO) by CF Finance Acquisition Corp. III (not Aeye, Inc., as noted in the metadata request) on November 17, 2020. The registrant is a Delaware corporation and an emerging growth company.
Key Financial Metrics
- Gross Proceeds from IPO: $230,000,000 from the sale of 23,000,000 Units at $10.00 per Unit (including 3,000,000 units from the full exercise of the underwriters' over-allotment).
- Private Placement Proceeds: $5,000,000 from the sale of 500,000 Private Placement Units to the Sponsor at $10.00 per Unit.
- Total Capital Raised: $235,000,000.
- Trust Account Funding: $230,000,000 (comprised of $225,000,000 from IPO proceeds and $5,000,000 from Private Placement proceeds) deposited in a U.S.-based trust account at J.P. Morgan Chase Bank, N.A.
- Warrant Terms: Each Unit includes one-third of one redeemable warrant; whole warrants are exercisable for one share of Class A Common Stock at $11.50 per share.
- Revenue/Profit/Cash Flow: The filing text does not provide operating revenue, profit, or cash flow metrics as this is a pre-operational SPAC IPO filing.
Material Changes
The primary material change is the transition from a private entity to a publicly traded company on The Nasdaq Stock Market LLC. The company now has outstanding securities including Units (CFACU), Class A Common Stock (CFAC), and Redeemable Warrants (CFACW). An audited balance sheet as of November 17, 2020, reflecting these proceeds, was issued as Exhibit 99.1.
Outlook, Risks, and Contingencies
The filing does not contain specific management commentary on future business targets, guidance, or detailed risk factors beyond the standard structure of a SPAC IPO. The primary contingency noted is the placement of funds in a trust account, which is standard for SPACs to ensure capital is available for a future business combination.
Investor Verification Checklist
- Verify the audited balance sheet (Exhibit 99.1) to confirm the exact cash position and any initial expenses deducted from the trust.
- Confirm the trading status and ticker symbols (CFACU, CFAC, CFACW) on The Nasdaq Stock Market.
- Review the definitive prospectus for details on the underwriters' over-allotment option and the specific terms of the Private Placement Units.
- Check for subsequent filings regarding the identification of a target company for the business combination.